Rights Issue21 May 2026, 05:51 pm
Genpharmasec: No Deviation in Rights Issue Proceeds
AI Summary
Genpharmasec Ltd. reports no deviation or variation in the use of proceeds from its Rights Issue for the quarter ended March 31, 2026. The funds raised through the Rights Issue, amounting to ₹4,845.05 Lakhs, were utilized as per the objects stated in the Letter of Offer. This confirmation is in compliance with Regulations 32 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The Audit Committee has reviewed and confirmed the utilization of proceeds.
Key Highlights
- Genpharmasec confirms no deviation in use of Rights Issue proceeds for Q4 2026.
- Rights Issue raised ₹4,845.05 Lakhs, utilized as per Letter of Offer.
- Compliance with SEBI Regulations 32 regarding use of funds.
- Audit Committee reviewed and approved the utilization of proceeds.
- Funds allocated to various objectives including equity acquisition, debt repayment, and working capital.
Price Impact
More from GENPHARMA